Salaera’s MaxO2 ME+p devices are designed to help hospitals meet monitoring guidelines and improve patient safety during respiratory therapies.
RT’s Three Key Takeaways:
- Guideline Compliance: The Maxtec +P monitoring solutions are designed to help healthcare facilities meet American Association for Respiratory Care (AARC) guidelines for oxygen delivery systems.
- Integrated Monitoring: The MaxO2 ME+p monitor allows for continuous oxygen and pressure tracking during bubble continuous positive airway pressure (CPAP) therapy and can be integrated into existing blender systems.
- Moisture Management: The systems utilize proprietary Nafion tubing to simplify rainout management, which can reduce the clinical time and resources required for maintenance.
Salaera has introduced its +P Pressure Monitoring Solutions, including the MaxO2 ME+p and MaxBlend 2+p, designed to ensure hospital compliance with American Association for Respiratory Care (AARC) guidelines for oxygen delivery system monitoring.
The new solutions are intended to minimize patient exposure to various health risks and may prevent the need for more invasive interventions, according to product documentation. The systems aim to streamline oxygen delivery setups within healthcare facilities by providing clinicians with more precise data.
The MaxO2 ME+p Oxygen and Pressure Monitor is a monitor-only unit that provides continuous tracking during bubble continuous positive airway pressure (CPAP) therapy. The device is designed to integrate with existing blenders and flow meters to complete a monitoring setup. For facilities requiring a more centralized solution, the MaxBlend 2+p offers a fully integrated monitor, blender, and flowmeter.
A key feature of these systems is the use of proprietary moisture-controlling Nafion tubing. This component is designed to simplify and mitigate rainout management, which can save time and resources for clinical staff. “Salaera +P Pressure Monitoring Solutions ensure hospital compliance with AARC guidelines for oxygen delivery system monitoring,” according to Salaera.
By monitoring how patients respond to specific flow rates, oxygen levels, and pressure changes, healthcare providers can adjust settings on a more minute level. The company also offers a virtual simulator for the MaxO2 ME+p to allow clinicians to test the monitor and its interface.
Notes
*Nafion is a trademark of the Chemours Company FC LLC used under license by Salaera (Perma Pure LLC).
Sources
